为患有两种同步多重原发性肺癌的患者建立生存预测模型:多中心队列分析
Translational lung cancer research
|October 21, 2024
概括
这项研究开发了一种名谱,用于预测同步多重原发性肺癌 (SMPLC) 患者的生存率,但不包括那些有地玻璃结节的患者. 该模型准确地分层了切除的SMPLC患者的风险.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 生物统计学 生物统计学
背景情况:
- 同步多发性原发性肺癌 (SMPLC) 的预后预测因素仍然不清楚.
- 有限的研究存在于SMPLC的预后,特别是排除多焦点地玻璃/乳腺 (GG/L) 结节.
- 准确的生存预测对于管理SMPLC患者至关重要.
研究的目的:
- 开发和验证一个有效的诺莫格拉姆模型来预测SMPLC患者的存活率.
- 确定影响SMPLC患者预后的独立风险因素.
- 提供一个工具,以更好地理解和决策SMPLC管理.
主要方法:
- 一项多中心队列研究包括831名接受切除的SMPLC患者.
- 开发并使用培训 (n=499) 和外部 (n=332) 队列验证了一个名ogram模型.
- 使用C指数,NRI和IDI评估模型性能,并与TNM系统进行比较.
主要成果:
- 对于名ogram模型,有7个独立的风险因素被确定.
- 命名图表表现出良好的歧视性,C指数为0.827 (内部) 和0.784 (外部).
- 该模型在重新分类方面显著改善 (NRI:0.33,IDI:0.21) 并准确预测生存率.
结论:
- 一种新型的诺莫格拉姆模型准确地对切除的SMPLC患者的生存风险进行了分层.
- 这种工具可以帮助高风险SMPLC患者的临床决策.
- 命名图为了解SMPLC预后提供了宝贵的资源.
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:20Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155